Last edition
News about "CDSCO"
AstraZeneca Gains CDSCO Nod for Import of Eculizumab in India
Eculizumab is a monoclonal antibody used to treat Paroxysmal Nocturnal Hemoglobinuria (PNH) and Atypical Hemolytic Uremic Syndrome (aHUS) by inhibiting complement-mediated thrombotic microangiopathy.
CDSCO | 18/01/2025 | By Aishwarya
AstraZeneca India Secures CDSCO Approval for Durvalumab
AstraZeneca Pharma India has been granted permission to import for sale and distribution of Durvalumab 120 mg/2.4 mL and 500 mg/10 mL solution for infusion from the Central Drugs Standard Control Organisation (CDSCO).
CDSCO | 27/09/2024 | By Aishwarya
Hyderabad-based Bharat Biotech recalls typhoid vaccine batch owing to substandard quality
Hyderabad-based Bharat Biotech recalls typhoid vaccine batch owing to substandard quality
CDSCO | 09/06/2023 | By Sudeep Soparkar | 468
Chennai-based Global Pharma Healthcare in radar for exporting contaminated eye drops
The company has exported two consignments of 24 batches of ‘Artificial Tears’ to the US which were manufactured in 2021 and 2022<br />
CDSCO | 06/02/2023 | By Sudeep Soparkar | 508
Aurobindo Pharma JV gets SEC recommendation for pneumococcal 15 valent vaccine
PCV15 vaccine was developed by Tergene Biotech and manufactured at AuroVaccines
CDSCO | 29/12/2022 | By Sudeep Soparkar | 334
Dr Mansukh Mandaviya virtually inaugurates CDSCO Bhawan, South Zone in Chennai
It will facilitate drug, cosmetics safety and regulatory activities of southern States/UTs including Tamil Nadu, Puducherry, Kerala and Lakshadweep<br />
CDSCO | 23/12/2022 | By Sudeep Soparkar | 185
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy